John T. Schroeder

John T. Schroeder

Auto-generated profile, based on publicly available information

John T. Schroeder

The Department of Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins Asthma and Allergy Center, Johns Hopkins University , 5501 Hopkins Bayview Circle, Baltimore, Maryland 21224 (USA)

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in World Allergy Organization Journal
Verified
Journal Article
Open access
DMDean D. Metcalfe
Dean D. Metcalfe
RPRuby Pawankar
Ruby Pawankar
SASteven J Ackerman
Steven J Ackerman
CACem Akin
Cem Akin
FCFrederic Clayton
Frederic Clayton
Massimo TriggianiMassimo Triggiani
Massimo Triggiani
Read the latest articles of World Allergy Organization Journal at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature

15 February 2009 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
JSJohn T. Schroeder
John T. Schroeder
KCKristin L. Chichester
Kristin L. Chichester
ABAnja P. Bieneman
Anja P. Bieneman
Although IL-3 is commonly recognized for its growth factor-like activity, in vitro studies have long demonstrated a unique capacity for this cytokine to also augment the proinflammatory properties and phenotype of human basophils. In particular, basophils secrete mediators that are hallmarks in allergic disease, including vasoactive amines (e.g., histamine), lipid metabolites (e.g., leukotriene C4), and cytokines (e.g., IL-4/IL-13), which are all markedly enhanced with IL-3 pretreatment. This priming phenomenon is observed in response to both IgE-dependent and IgE-independent stimulation. Additionally, IL-3 directly activates basophils for IL-13 secretion and enhanced CD69 expression, two markers that are elevated in allergic subjects. Lymphocytes are commonly thought to be the source of the IL-3 that primes for these basophil responses. However, we demonstrate herein for the first time that basophils themselves rapidly produce IL-3 (within 4 h) in response to IgE-dependent activation. More importantly, our findings definitively show that basophils rapidly bind and utilize the IL-3 they produce, as evidenced by functional and phenotypic activity that is inhibited in the presence of neutralizing anti-IL-3 receptor (CD123) Abs. We predict that autocrine IL-3 activity resulting from low-level IgE/FcεRI cross-linking by specific allergen represents an important mechanism behind the hyperreactive nature of basophils that has long been observed in allergic disease.

20 June 2011 in Immunological Reviews
Verified
Journal Article
Closed access
PDF file
JSJohn T. Schroeder
John T. Schroeder

1 April 2010 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
JSJohn T. Schroeder
John T. Schroeder
ABAnja P. Bieneman
Anja P. Bieneman
KCKristin L. Chichester
Kristin L. Chichester
RHRobert G. Hamilton
Robert G. Hamilton
HXHuiQing Xiao
HuiQing Xiao
MLMark C. Liu
Mark C. Liu

21 September 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
JCJonathan D. Crawford
Jonathan D. Crawford
HWHong Wang
Hong Wang
DTDaniela Trejo-Zambrano
Daniela Trejo-Zambrano
IMIvana Munitic
Ivana Munitic
CTC. Conover Talbot
C. Conover Talbot
EDErika Darrah
Erika Darrah
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a dramatic sex bias, affecting 9 times more women than men. Activation of Toll-like receptor 7 (TLR7) by self-RNA is a central pathogenic process leading to aberrant production of type I interferon (IFN) in SLE, but the specific RNA molecules that serve as TLR7 ligands have not been defined. By leveraging gene expression data and the known sequence specificity of TLR7, we identified the female-specific X-inactive specific transcript (XIST) long noncoding RNA as a uniquely rich source of TLR7 ligands in SLE. XIST RNA stimulated IFN-α production by plasmacytoid DCs in a TLR7-dependent manner, and deletion of XIST diminished the ability of whole cellular RNA to activate TLR7. XIST levels were elevated in blood leukocytes from women with SLE compared with controls, correlated positively with disease activity and the IFN signature, and were enriched in extracellular vesicles released from dying cells in vitro. Importantly, XIST was not IFN inducible, suggesting that XIST is a driver, rather than a consequence, of IFN in SLE. Overall, our work elucidated a role for XIST RNA as a female sex–specific danger signal underlying the sex bias in SLE.

1 April 2021 in Seminars in Immunology
Verified
Journal Article
Closed access
Gilda VarricchiGilda Varricchi
Gilda Varricchi
Remo PotoRemo Poto
Remo Poto
Gianni MaroneGianni Marone
Gianni Marone
JSJohn T. Schroeder
John T. Schroeder